AbbVie Benefitted from Top-Line Growth From Its Immunosuppressive Drugs
| ABBV Stock | USD 171.56 2.14 1.23% |
Slightly above 62% of AbbVie's investor base is looking to short. The analysis of the overall investor sentiment regarding AbbVie Inc suggests that many traders are alarmed. AbbVie's investing sentiment can be driven by a variety of factors including economic data, AbbVie's earnings reports, geopolitical events, and overall market trends.
AbbVie |
Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the same can be downloaded here.
Read at insidermonkey.com
 |
AbbVie Inc Current Investor Sentiment
Panic Vs Confidence
38
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use AbbVie's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward AbbVie Inc.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
AbbVie Inc Historical Investor Sentiment
Investor biases related to AbbVie's public news can be used to forecast risks associated with an investment in AbbVie. The trend in average sentiment can be used to explain how an investor holding AbbVie can time the market purely based on public headlines and social activities around AbbVie Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AbbVie's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AbbVie and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average AbbVie news discussions. The higher the estimate score, the more favorable the investor's outlook on AbbVie.
AbbVie Maximum Pain Price Across April 17th 2025 Option Contracts
AbbVie's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of AbbVie close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of AbbVie's options.
AbbVie Fundamental Analysis
We analyze AbbVie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
AbbVie is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
AbbVie Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AbbVie stock to make a market-neutral strategy. Peer analysis of AbbVie could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics with similar companies.
Peers
AbbVie Related Equities
| AMGN | Amgen | 0.99 | ||||
| GILD | Gilead Sciences | 0.21 | ||||
| BMY | Bristol Myers | 0.16 | ||||
| JNJ | Johnson Johnson | 0.50 | ||||
| PFE | Pfizer | 0.72 | ||||
| MRK | Merck | 2.76 | ||||
| LLY | Eli Lilly | 4.21 |
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.